Stephens initiated coverage on Thermo Fisher Scientific, recognizing its industry leadership in life sciences with a projected $42.9 billion sales in 2023. The company's strategic mergers and acquisitions have bolstered its presence in the biopharma sector, offering growth potential and margin expansion opportunities.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing